DUBAI, UAE – UAE’s Ministry of Health and Prevention (MoHAP) discussed with the Russian Ministry of Industry and Trade ways to boost collaboration, exchange medical expertise and expand partnerships in the pharmaceutical sector between the two countries.
The two countries also discussed ways and means to encourage more Russian companies to transfer some of their production lines to the UAE.
The ministry briefed the Russian delegation on the UAE’s conducive environment provided to encourage investments in the pharmaceutical sector in accordance with the best international practices.
Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector, MoHAP and Vladislav Shestakov, Director of the State Institute of Medicines and Good Practices of the Ministry of Industry and Trade of Russia, held the discussions at MoHAP’s headquarters in Dubai.
The two sides also reviewed the latest achievements and pharmaceutical innovations in the two countries and explored avenues of attracting more Russian pharmaceutical companies and factories to the UAE, as well as expanding the presence of Emirati pharmaceutical products in the Russian market.
Al Amiri said that the two sides had an opportunity to review the best international practices in the field of pharmaceutical manufacturing.
The two sides agreed on the need to expand partnerships with countries that have expertise in pharmaceutical sector to further strengthen the local industrial base, support the sustainability of health services in the UAE and satisfy the needs of all patients.
He said the meeting with the Russian officials comes as part of the ministry’s keenness to foster partnerships in the pharmaceutical industries by offering a supportive environment to produce medical preparations.
This would help in improving the nation’s pharmaceutical stockpile and ensure a steady supply of medicines.
Vladislav Shestakov said Russia is keen to strengthen its cooperation with the UAE to serve the pharmaceutical sectors of both nations.
He spoke highly of the impressive development and advanced infrastructure of the UAE’s health system, especially pharmaceuticals and lauded the country’s conducive environment created to attract global companies in the sector wishing to expand their markets in the region.